Considering all of these inquiries and our experiment results, further experimental validation is urgently needed to carefully uncover the interactions between Siglec9 and these identified proteins and figure out their biological consequences in the bladder cancer microenvironment. The gene discussed is SIGLEC9; the disease is urinary bladder cancer.